OPRA Q1 2026 Earnings EPS Tops Estimates as Opera Delivers Modest Beat ELBM Q4 2025 Earnings Significant EPS Miss as PreRevenue Company Navigates Development Phase BMEA Q1 2026 Earnings NarrowerthanExpected Loss Highlights Progress in Clinical Pipeline ALDX Q1 2026 Earnings Narrowed Loss Beats Expectations as Pipeline Progress Takes Center Stage ABEV Q1 2026 Earnings EPS Misses Estimates as Cost Pressures Weigh KLAR Q1 2026 Earnings NarrowerThanExpected Loss Drives Positive Market Response